Coadministration has not been studied. Amlodipine is metabolized by CYP3A4. Darunavir/cobicistat could potentially increase amlodipine exposure. Caution is warranted and clinical monitoring of therapeutic and adverse effects is recommended. Amlodipine should be started at low doses with careful titration to response.